Tag: Richard P. Baum

Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE